Afinitor 5 mg/1 (everolimus TABLET) 5 mg/1

Afinitor 5 mg tablets contain everolimus, a medication used to manage certain medical conditions. This oral treatment is designed to support specific therapeutic needs, offering a convenient dosage form for consistent administration.

Strength

5 mg/1

Pack Size

28 BLISTER PACK in 1 CARTON (0078-0566-51) / 1 TABLET in 1 BLISTER PACK (0078-0566-61)

Manufacturer / TM Owner

Novartis Pharmaceuticals Corporation

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Afinitor 5 mg tablets are primarily used to support the management of conditions that require targeted therapy. Everolimus, the active ingredient, is often utilized in scenarios where precise control of cellular processes is necessary. Patients and healthcare providers may explore what is Afinitor used for in contexts such as supportive care or specific therapeutic protocols.

Side Effects

Common effects of Afinitor 5 mg tablets may include mild to moderate reactions that vary among individuals. Some users might experience changes in appetite, fatigue, or skin conditions. It's important to monitor any effects and consult a healthcare professional if concerns arise.

Precautions & Warnings

Handling Afinitor 5 mg tablets requires adherence to safety guidelines to ensure proper use. Store the medication as directed, typically at room temperature, and keep it out of reach of children. Always follow the advice of a healthcare provider regarding administration and storage.

Avoid Interactions

Afinitor 5 mg tablets may interact with certain substances, including other medications, supplements, or specific foods. It's advisable to discuss all current treatments with a healthcare provider to avoid potential interactions. Alcohol and certain CYP inhibitors might influence the effectiveness or safety of everolimus.

References

Frequently Asked Questions

Afinitor 5 mg tablets are used to support the management of specific medical conditions that require targeted therapy. The active ingredient, everolimus, is designed to address certain cellular processes.

Afinitor 5 mg tablets should be stored at room temperature, away from moisture and heat. Keep the medication in its original packaging and out of reach of children.

Common effects of Afinitor 5 mg tablets may include changes in appetite, fatigue, or skin conditions. Individual experiences can vary, and it's important to monitor any reactions.

Yes, Afinitor 5 mg tablets may interact with other medications, supplements, or specific foods. It's advisable to discuss all current treatments with a healthcare provider to avoid potential interactions.

If you miss a dose of Afinitor 5 mg tablets, consult your healthcare provider for advice. Do not double the dose to make up for a missed one.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.